about
A vasoactive role for endogenous relaxin in mesenteric arteries of male mice.Differential effects of relaxin deficiency on vascular aging in arteries of male mice.Serelaxin Elicits Bronchodilation and Enhances β-Adrenoceptor-Mediated Airway Relaxation.Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin-mediated relaxation after in vivo serelaxin treatmentAcute intravenous injection of serelaxin (recombinant human relaxin-2) causes rapid and sustained bradykinin-mediated vasorelaxation.Time-dependent activation of prostacyclin and nitric oxide pathways during continuous i.v. infusion of serelaxin (recombinant human H2 relaxin)Serelaxin: A Novel Therapeutic for Vascular Diseases.Vascular actions of relaxin: nitric oxide and beyond.Does serelaxin treatment alter passive mechanical wall properties in small resistance arteries?Increased superoxide production and altered nitric oxide-mediated relaxation in the aorta of young but not old male relaxin-deficient mice.Animal models of preeclampsia: translational failings and why.Short-term (48 hours) intravenous serelaxin infusion has no effect on myogenic tone or vascular remodeling in rat mesenteric arteries.The peptide hormone relaxin: from bench to bedside.Enhanced uterine artery stiffness in aged pregnant relaxin mutant mice is reversed with exogenous relaxin treatment.Adverse vascular remodelling is more sensitive than endothelial dysfunction to hyperglycaemia in diabetic rat mesenteric arteries.Relaxin Deficiency Leads to Uterine Artery Dysfunction During Pregnancy in Mice.From pregnancy to cardiovascular disease: Lessons from relaxin-deficient animals to understand relaxin actions in the vascular system
P50
Q34226848-F0A9EAF0-4F6F-4FAC-881F-86DFD2C55CCDQ35779682-0278D30C-08E9-42F9-8306-F425AE7B5EFCQ37368923-4ECA86E2-961B-420E-B7CE-8B28BCB31E13Q37405208-947D2AEC-7B60-48AB-8318-0AD3612C0327Q37648577-8ECD21A8-34C7-4C1E-A274-D035DD9F1847Q37686150-0BFAF1C6-D733-4027-8CCB-EE5B82B0A6F9Q38821411-7ADC2F9A-1F00-4A27-B0AD-4D8D4EB6AC2DQ38945156-D38DC46A-F9FC-4339-B82A-EACDF54B325AQ38960703-300498DB-C128-4833-B800-5FBC947480BFQ40958055-8114530A-E824-4DA0-8355-75C1BEA576A6Q46300987-BD41F422-E175-4144-8559-54E52D4B7E1DQ48331109-446BCD56-6C23-4A21-A588-A43166FBB15FQ50141057-320607C2-FB99-4EF7-AB57-35E64F76659FQ50952234-A5EAD134-0E93-4705-BDF5-55169ADEA2CDQ51671566-F839434B-1B7B-4F9C-B494-A86B11555275Q55242384-A1CB7C27-3E81-4427-BA15-2A47F5D5C113Q89018502-E50A5A0C-82B2-46A1-8193-02A3F12B57E0
P50
description
researcher ORCID ID = 0000-0001-9773-4972
@en
wetenschapper
@nl
name
Maria Jelinic
@ast
Maria Jelinic
@en
Maria Jelinic
@es
Maria Jelinic
@nl
type
label
Maria Jelinic
@ast
Maria Jelinic
@en
Maria Jelinic
@es
Maria Jelinic
@nl
prefLabel
Maria Jelinic
@ast
Maria Jelinic
@en
Maria Jelinic
@es
Maria Jelinic
@nl
P21
P31
P496
0000-0001-9773-4972